rct
    2022

    Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults

    Singh A, DAmico D, Andreux PA

    Published in Cell Reports Medicine

    Methodology

    Randomized double-blind placebo-controlled 4-month trial of Urolithin A 500 mg or 1000 mg daily in middle-aged adults

    Key Findings

    Urolithin A improved muscle strength in hand and leg measures and reduced plasma inflammatory and mitochondrial biomarkers versus placebo

    Conclusions

    Urolithin A improves muscle strength and mitochondrial biomarkers in middle-aged adults

    Limitations

    Industry sponsored; aerobic endurance endpoints were not all significant

    Supplements Studied

    Urolithin A
    Compound

    Urolithin A improved muscle strength and reduced plasma inflammatory and mitochondrial biomarkers versus placebo

    Outcomes Measured

    Urolithin A improved hand and leg muscle strength versus placebo

    Related Health Concerns

    Study Details

    Year:2022
    Sample Size:88
    Duration:16 weeks
    Quality Score:6/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.